Use of subhuman primates in experimental infections.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D000882:Haplorhini; D006660:Histoplasmosis / Q000453:epidemiology; D007239:Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality; D008297:Male; D008954:Models, Biological; D009976:Orthomyxoviridae Infections / Q000453:epidemiology; D011008:Pneumococcal Infections / Q000453:epidemiology; D012373:Rocky Mountain Spotted Fever / Q000453:epidemiology; D013203:Staphylococcal Infections / Q000453:epidemiology; D013290:Streptococcal Infections / Q000453:epidemiology; D014406:Tularemia / Q000453:epidemiology
D000900:Anti-Bacterial Agents